Skip to content

The Impact of Pulmonary Rehabilitation on Dyspnea in Chronic Obstructive Pulmonary Disease

Mechanisms of Dyspnea Relief Following Exercise Training in COPD

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01513616
Enrollment
48
Registered
2012-01-20
Start date
2006-11-30
Completion date
2011-12-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, dyspnea, exercise, measurement, respiratory physiology

Brief summary

Dyspnea (respiratory discomfort) and activity limitation are the most common symptoms of chronic obstructive pulmonary disease (COPD) and contribute importantly to a perceived poor quality of life. Recent international guidelines have stressed the importance of dyspnea alleviation and improvement exercise tolerance as a means of enhancing quality of life and other long term outcomes in this population. Modern pharmacotherapy is the first step in symptom management but the overall impact of bronchodilator therapy is relatively small. Exercise training remains the most effective treatment for ameliorating dyspnea and improving exercise endurance and was the main focus of this study. The main objectives of the study were: 1. To conduct and compare detailed studies of respiratory mechanics during cycle exercise before and after exercise training (EXT) compared with an untrained control group. By multiple regression analysis, the investigators will establish the main contributors to dyspnea relief after EXT. 2. To compare the magnitude of change in endurance during constant work rate cycle exercise with those measured during walk tests and the endurance shuttle walk test after EXT relative to control. To evaluate which test (constant work rate cycle, six-minute walk test, or endurance shuttle walk test) is the most sensitive test for measuring changes in endurance after EXT versus control. 3. To compare the change in standardized dyspnea ratings (Borg Scale) during constant-load cycling with a variety of other activity-related dyspnea questionnaires. To evaluate which of these measurements is the most sensitive for examining changes in perceived discomfort during exercise. 4. To evaluate the contribution of psychological factors (anxiety, fear, respiratory panic, self-efficacy) to the perceived improvement of symptoms following EXT. The investigators will use multiple regression analysis to examine associations between changes in perceived dyspnea and changes in anxiety and self-efficacy measured by validated questionnaires and Borg intensity ratings?

Interventions

OTHERPulmonary rehabilitation

8-week program, 3 supervised session per week

OTHERUsual care

An 8-week control period (includes optimization of respiratory medications, instructions on how best to manage COPD, standard access to treatment in the event of an exacerbation, self-management education)

Sponsors

Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of COPD * clinically stable * presence of activity-related dyspnea (Baseline Dyspnea Index \< 9) * 40-80 years of age

Exclusion criteria

* other significant disorders or diseases that could interfere with conduct of the intervention or tests * body mass index \< 18 or \> 40 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Exertional dyspnea intensity8 weeksPost-intervention comparisons (pulmonary rehabilitation vs. usual care control) of dyspnea measurements (i.e., Borg ratings at a standardized time during high-intensity constant-work rate cycle exercise testing)

Secondary

MeasureTime frameDescription
Multidimensional measurements of dyspnea and physiological measurements8 weeksActivity-related dyspnea: MRC dyspnea scale, Transition Dyspnea Index, CRQ dyspnea component, SGRQ activity component
Dyspnea-related anxiety8 weeksIntensity of dyspnea-related anxiety measured during cycle exercise testing (Borg scale)
disease-specific self-efficacy8 weeksCOPD Self-Efficacy Score
Pulmonary function8 weeksDetailed measurements of pulmonary function: spirometry, body plethysmography, diffusing capacity, maximal respiratory pressures
Cardiopulmonary exercise test measurements8 weeksPhysiological measurements obtained during cycle exercise testing

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026